Several molecules identified in our study, including TIMP1, CD36, DAB2, and miR-181b-5p, have been previously reported to be enriched in EVs derived from BC cells, as documented in EV-specific repositories such as Vesiclepedia and ExoCarta [13,14]. Here, CD36 is linked to breast cancer.